We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+4.57%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.79B
AUM Growth
-$730M
Cap. Flow
-$661M
Cap. Flow %
-23.73%
Top 10 Hldgs %
39.61%
Holding
2,225
New
423
Increased
362
Reduced
424
Closed
673
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HEPS
1176
D-Market Electronic Services & Trading
HEPS
$1.04B
$69K ﹤0.01%
71,399
+11,681
+20% +$11.1K
AMC icon
1177
CALL
AMC Entertainment Holdings
AMC
$2.14B
$68K ﹤0.01%
5,830
-1,290
-18% -$176K
DAKT icon
1178
Daktronics
DAKT
$1.02B
$68K ﹤0.01%
25,000
-15,784
-39% -$54.3K
TAOX
1179
Tao Synergies Inc
TAOX
$26.9M
$68K ﹤0.01%
403
-172
-30% -$29.8K
BRSP
1180
BrightSpire Capital
BRSP
$628M
$67K ﹤0.01%
10,611
-37
-0.3% -$306
PBI icon
1181
Pitney Bowes
PBI
$2.28B
$65K ﹤0.01%
27,814
+7,073
+34% +$22.7K
SIRI icon
1182
SiriusXM
SIRI
$9.65B
$65K ﹤0.01%
+1,141
New +$71.7K
OSUR icon
1183
OraSure Technologies
OSUR
$270M
$64K ﹤0.01%
+16,900
New +$61.1K
TERN
1184
DELISTED
Terns Pharmaceuticals
TERN
$64K ﹤0.01%
+10,945
New +$40.7K
NBP
1185
NovaBridge Biosciences American Depositary Shares
NBP
$213M
$63K ﹤0.01%
15,620
-4,531
-22% -$34.4K
MOMO
1186
Hello Group
MOMO
$861M
$63K ﹤0.01%
+13,736
New +$65.8K
OMIC
1187
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$62K ﹤0.01%
830
-222
-21% -$23.2K
KRON
1188
DELISTED
Kronos Bio
KRON
$61K ﹤0.01%
+18,110
New +$81.7K
ORGO icon
1189
Organogenesis Holdings
ORGO
$242M
$58K ﹤0.01%
+18,024
New +$81.4K
ARQ icon
1190
Arq
ARQ
$93.1M
$57K ﹤0.01%
20,800
+7,900
+61% +$33.4K
ATVI
1191
CALL
DELISTED
Activision Blizzard
ATVI
$57K ﹤0.01%
25,700
-10,000
-28% -$783K
RSX
1192
DELISTED
VanEck Russia ETF
RSX
$56K ﹤0.01%
13,122
AMC icon
1193
AMC Entertainment Holdings
AMC
$2.14B
$55K ﹤0.01%
+2,045
New +$279K
MJ icon
1194
Amplify Alternative Harvest ETF
MJ
$109M
$55K ﹤0.01%
1,000
MSOS icon
1195
CALL
AdvisorShares Pure US Cannabis ETF
MSOS
$924M
$55K ﹤0.01%
13,400
-900
-6% -$10.4K
SLND.WS icon
1196
Southland Holdings Warrants
SLND.WS
$1.28M
$55K ﹤0.01%
150,000
ZVIA icon
1197
Zevia
ZVIA
$108M
$55K ﹤0.01%
12,781
-3,942
-24% -$16K
ET icon
1198
CALL
Energy Transfer Partners
ET
$71.7B
$52K ﹤0.01%
100,000
OLMA icon
1199
Olema Pharmaceuticals
OLMA
$903M
$52K ﹤0.01%
18,751
-9,256
-33% -$39.3K
ALTO icon
1200
Alto Ingredients
ALTO
$319M
$50K ﹤0.01%
+13,600
New +$57.3K

Similar funds

Prelude Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Prelude Capital Management held 2,225 positions worth $2.79B, down 21% from $3.52B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Prelude Capital Management withdrew a net $661M in Q3 2022, closing 673 positions and reducing 424 holdings. Its most notable exit was KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant, an estimated $43.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.

Against the trend, Prelude Capital Management opened a new position in KKR Acquisition Holdings I Corp. worth $30.7M.

  • Prelude Capital Management's largest Q3 2022 buy was KKR Acquisition Holdings I Corp.: 3,123,025 shares worth $30.7M.
  • Prelude Capital Management added most to Twitter, Inc. in Q3 2022, an estimated $23.5M increase.
  • Prelude Capital Management's biggest Q3 2022 reduction was Lockheed Martin, cutting an estimated $83M.
  • Prelude Capital Management fully exited KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant in Q3 2022, selling an estimated $43.2M.
  • Prelude Capital Management's ten largest holdings make up 40% of its $2.79B portfolio in Q3 2022.
  • Prelude Capital Management opened 423 new positions and closed 673 in Q3 2022.
  • Prelude Capital Management's portfolio value fell 21% quarter-over-quarter to $2.79B.

Based on Prelude Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.